Capital Management Corp VA Cuts Stock Holdings in LifeVantage Co. (NASDAQ:LFVN)

Capital Management Corp VA lowered its position in shares of LifeVantage Co. (NASDAQ:LFVN) by 28.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 301,585 shares of the company’s stock after selling 118,345 shares during the quarter. Capital Management Corp VA’s holdings in LifeVantage were worth $5,287,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the company. Barclays PLC raised its stake in shares of LifeVantage by 38.2% in the third quarter. Barclays PLC now owns 41,966 shares of the company’s stock worth $507,000 after purchasing an additional 11,608 shares during the last quarter. HighTower Advisors LLC bought a new stake in LifeVantage in the 3rd quarter worth about $638,000. Ritholtz Wealth Management raised its position in LifeVantage by 65.2% in the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock worth $830,000 after buying an additional 18,682 shares during the last quarter. Copeland Capital Management LLC bought a new position in LifeVantage during the 4th quarter valued at about $65,000. Finally, Bank of New York Mellon Corp boosted its holdings in shares of LifeVantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock valued at $1,300,000 after acquiring an additional 22,620 shares during the last quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

LifeVantage Stock Down 0.1 %

NASDAQ LFVN opened at $15.40 on Friday. The firm has a market capitalization of $193.29 million, a P/E ratio of 27.50 and a beta of 0.84. The company has a 50-day moving average price of $19.93 and a 200-day moving average price of $15.14. LifeVantage Co. has a 52 week low of $5.22 and a 52 week high of $27.38.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 1.04%. The ex-dividend date is Monday, March 3rd. LifeVantage’s dividend payout ratio is presently 28.57%.

Insiders Place Their Bets

In related news, Director Raymond B. Greer sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the completion of the transaction, the director now directly owns 99,288 shares in the company, valued at approximately $2,000,653.20. The trade was a 7.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 20.65% of the company’s stock.

Analysts Set New Price Targets

LFVN has been the topic of a number of research analyst reports. Lake Street Capital began coverage on shares of LifeVantage in a research report on Thursday, December 19th. They set a “buy” rating and a $26.00 price objective on the stock. Craig Hallum initiated coverage on LifeVantage in a report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price target on the stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.